Vanguard Personalized Indexing Management, LLC Cytokinetics Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 13,591 shares of CYTK stock, worth $694,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,591
Previous 12,082
12.49%
Holding current value
$694,907
Previous $485,000
7.42%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
369Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$900 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$750 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$613 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$400 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$326 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.81B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...